WikiPeptidiaSearch
Research Purposes Only — All information on this page is intended strictly for scientific and educational research purposes. Content including compound descriptions, dosing data, protocols, and mechanistic overviews is derived from publicly available literature and is provided solely to support the research community. Nothing here constitutes medical advice, a clinical recommendation, or an endorsement of any substance for human use. Compounds described may be restricted in certain jurisdictions — readers are solely responsible for compliance with all applicable laws. Always consult a licensed healthcare professional before making any health-related decisions.

Syn-Coll (Palmitoyl Tripeptide-5)

Syn-Coll (Palmitoyl Tripeptide-5) is a cosmetic peptide that stimulates collagen production to reinforce the dermal matrix and improve skin firmness

Syn-Coll is a palmitoyl-conjugated tripeptide that mimics thrombospondin-1 to persistently activate TGF-β signaling in dermal fibroblasts, boosting type I collagen synthesis by 2-3 fold over 72 hours while inhibiting matrix metalloproteinases (MMPs) to prevent degradation—achieving 14% fine line reduction and 8.8% elasticity improvement in 84 days. The lipidation enhances penetration 10-fold versus non-palmitoylated peptides, sustaining collagen production beyond transient stimulators.

Clinical trials show 27% dermal density increase and sustained hydration via hyaluronic acid upregulation, remodeling skin matrix for visible firmness without irritation. Synergistic with Matrixyl 3000, it addresses chronological and photoaging through multifaceted ECM restoration. Applied topically (1-3% concentration), Syn-Coll offers structural skin rejuvenation mimicking youthful collagen dynamics, ideal for mature skin seeking measurable density and elasticity gains.

Syn-Coll (Palmitoyl Tripeptide-5) – Benefits & Side Effects

Benefits: A bioactive peptide that stimulates the production of TGF-beta, the body's key element for collagen synthesis. It significantly improves skin texture, reduces the appearance of wrinkles, and helps repair the damage caused by UV exposure.
Side Effects: Topically used with an excellent safety record; no significant skin irritation or systemic side effects have been noted in cosmetic evaluations.

Syn-Coll (Palmitoyl Tripeptide-5) – Protocol

Syn-Coll (Palmitoyl Tripeptide-5)

Research Goal: Assessing the "Collagen Booster" effect by mimicking the human body’s own mechanism to activate latent TGF-β, leading to extracellular matrix remodeling.

Preparation: Typically used as a topical liquid, formulated at a concentration of 1% to 3%.

Application Schedule (Topical)

Research Objective Concentration Frequency
Collagen Induction 3% Solution Twice Daily
Texture Improvement 1% Solution Once Daily
  • Frequency: Twice daily (AM/PM).
  • Timing: Apply to clean, dry skin.
  • Cycle Length: 8–12 weeks.

Syn-Coll (Palmitoyl Tripeptide-5) – Lifestyle Considerations

Maintain a diet rich in Vitamin C, copper, and essential amino acids to provide the building blocks for the collagen synthesis stimulated by this TGF-beta activating peptide. Prioritize 7–9 hours of nightly sleep to allow the skin to enter its peak regenerative cycle, where the peptide’s signaling for structural remodeling is most potent. Maintain a consistent skincare regimen including barrier-supporting moisturizers and broad-spectrum SPF to protect the newly formed collagen network from UV-induced degradation. Avoid smoking and excessive sugar intake, which can cause glycation and damage the very fibers the peptide is attempting to strengthen and repair.

Proper Peptide Storage

Why Proper Peptide Storage Matters

Peptides are delicate molecules sensitive to temperature, moisture, light, and repeated freeze-thaw cycles. Incorrect storage can lead to degradation, loss of potency, and reduced efficacy. Following these guidelines ensures your research peptides maintain maximum stability and bioactivity throughout their shelf life.

Lyophilized (Powder) Peptides

Optimal Storage:

  • Freezer: Store at -20°C (-4°F) or below (ideally -80°C for long-term storage up to 2-3 years).
  • Short-term: Refrigerate at 2-8°C (35.6-46.4°F) for weeks to months.
  • Room temperature: Acceptable for short periods (days to weeks) if dry and protected from light, but not recommended for extended storage.
  • After reconstitution: inspect for discoloration or clumping before use.

Key Practices:

  • Keep in original sealed packaging with desiccant to minimize moisture exposure.
  • Store in a dry, dark environment—peptides are hygroscopic and light-sensitive.
  • Allow vials to reach room temperature before opening to prevent condensation, which can degrade the powder.

Reconstituted (Liquid) Peptides

Refrigeration is Essential:

  • Use quality bacteriostatic water: Stick to quality brands like Hospira.
  • Store at 2-8°C (35.6-46.4°F) immediately after reconstitution.
  • Use within 4 weeks (28 days) for optimal potency when using bacteriostatic water (0.9% benzyl alcohol).
  • Discard after this period, even if solution remains—preservative efficacy diminishes.

Important Warnings:

  • Do NOT freeze reconstituted solutions—freezing denatures peptides.
  • Avoid freeze-thaw cycles—they cause irreversible degradation. If long-term storage is needed beyond 4 weeks: Aliquot into sterile single-use vials, Freeze aliquots at -20°C (-4°F) for up to 3-6 months, and thaw each aliquot only once.

Handling Peptides Best Practices

  1. Before Opening: Always let lyophilized vials equilibrate to room temperature (10-30 minutes) to avoid condensation inside the vial.
  2. Light Protection: Wrap vials in foil or store in opaque containers—UV light accelerates degradation.
  3. Reconstituted Peptides Inspection: Before each use, check for Clarity (should be colorless/clear with no cloudiness, particles, or discoloration). Discard if any issues observed.
  4. Aseptic Technique: Swab stopper with alcohol, use sterile needles/syringes per draw.
  5. Labeling: Mark reconstitution date on vials.

Common Peptide Storage Mistakes to Avoid

  • Moisture Exposure: Never store open vials; always reseal tightly.
  • Temperature Fluctuations: Avoid door storage in fridge/freezer.
  • Heat/Light: Keep away from direct sunlight, heaters, or lab lights.
  • Overuse of Multi-Dose Vials: Follow 28-day rule per USP/CDC guidelines.
  • Freezing Liquids: Repeated cycles can reduce potency by 25%+ per cycle.

Special Peptide Considerations

  • Above guidelines are consolidated from industry best practices for research peptides, for peptide-specific variations, consult lab documentation. Examples below highlight how specialized peptides can differ:
  • HCG & HMG: Refrigerate lyophilized; reconstituted stable 60 days max (HCG), use promptly (HMG).
  • NAD+: Extremely hygroscopic—use -80°C for powder; refrigerate liquid ≤14 days.
  • PT-141: Room temp stable short-term; refrigerate reconstituted ≤1 week.

Subcutaneous Peptide Injection Protocol

Subcutaneous Peptide Injection Protocol Overview

This guide synthesizes standardized subcutaneous injection techniques, site selection, and safety practices. Core principles: sterile preparation, 45-90° needle insertion (90° preferred for short needles ≥4-6mm in ample fat; pinch skin & use 45° if lean), slow steady injection over 5-10 seconds, systematic site rotation, and immediate sharps disposal.

Preparation & Supplies

  • Hand Hygiene: Wash thoroughly with soap and water.
  • Materials: U-100 insulin syringe (1 mL, 29-31G needle, 5/16-1/2"), alcohol swabs (70%), sharps container, gauze. Use 30-50 unit syringes for volumes <10 units.
  • Vial Prep: Wipe stopper, dry 10-30 seconds, draw dose, tap out air bubbles. Warm vials to room temperature to reduce stinging.
  • Volume Limit: ≤1.5 mL per site; split larger doses (e.g., 75 IU into 3x25 IU). For doses under 10 units, consider using 30-unit or 50-unit insulin syringes to ensure measurement accuracy.

Site Selection & Rotation

Choose areas with adequate subcutaneous fat; avoid scars, moles, or irritation. Systematically rotate sites 1-1.5 inches apart; avoid same spot for 1-2 weeks. Log sites to prevent lipohypertrophy/lumping:

  • Abdomen: ≥2 inches from navel (least sensitive, ample fat)
  • Outer Thighs: Middle third, anterior-lateral
  • Upper Arms: Back/outer (triceps)
  • Upper Buttocks/Flank: Supplemental for frequent protocols

Peptide Injection Technique

Proper peptide injection technique is essential for ensuring safety, maximizing efficacy, and maintaining consistent absorption. To prevent lumps and irritation, use sharp, room-temperature needles and avoid deep injections with dull needles. Always maintain a sterile environment by using benzyl alcohol and ensuring the injection site is fully relaxed:

  1. Clean site outward in circles; air-dry 30 seconds.
  2. Pinch 1-2 inch skin fold to lift subcutaneous layer.
  3. Insert needle at 45-90° angle (90° for ample fat, 45° for lean/thin needle).
  4. No aspiration (pulling back plunger to check for blood)
  5. Inject slowly/steadily over 3-10 seconds; hold 5-10 seconds post-injection.
  6. Withdraw at same angle; gentle pressure if bleeding.
  7. Dispose in sharps container immediately; never recap.
  8. Discard any reconstituted solution if it becomes cloudy. Bacteriostatic water and reconstituted vials should typically be discarded within 28 days of opening or mixing.

Peptide Injection Timing Consideration

  • Nocturnal Alignment: Administer Growth Hormone Secretagogues (Sermorelin, GHRPs) on an empty stomach before bed to align with the body’s natural nocturnal growth hormone pulses.
  • Frequency Limits: Adhere to strict administration caps for specific compounds, such as PT-141, which should not exceed one dose per 24 hours or eight doses per month.
  • Half-Life Scheduling: Match dosing frequency to the peptide's half-life, such as weekly administration for CJC-1295 DAC versus daily dosing for Ipamorelin.
  • Titration Timing: Utilize a gradual dose escalation (titration) schedule over several weeks for GLP-1 agonists to minimize gastrointestinal side effects.
  • Co-administration: If using multiple healing peptides like BPC-157 and TB-500 on the same day, ensure they are administered at different injection sites.
  • Consistency & Documentation: Maintain a strict daily administration time and log it alongside site rotation to ensure a stable biological baseline and accurate response tracking.

Peptide Post-Injection Care & Risks

This guide prioritizes safety, efficacy, and consistent absorption for optimal peptide administration:

  • Monitor for redness/swelling; rest site 1-7 days if severe.
  • No massage (disrupts absorption).
  • Document dose, site, time, reactions.
  • Lipohypertrophy: Caused by rotation failure; prevent with systematic site changes.
  • Pain/Lumps: From deep injection, cold solution, or dull needles.
  • Infection: Maintain asepsis; monitor for fever/redness.

Syn-Coll (Palmitoyl Tripeptide-5) – Identification

Common Names: Syn-Coll, SYN-COLL, Palmitoyl Tripeptide-5, Palmitoyl-Lys-Val-Lys, Pal-KVK, Tripeptide-5, Collagen Peptide COLL-O2

CAS Number: 623172-55-4 (primary free base); 623172-56-5 (trifluoroacetate salt form)

Molecular Formula: C₃₃H₆₅N₅O₅ (free base); C₃₅H₆₆F₃N₅O₇ (trifluoroacetate salt form)

Molecular Weight: 611.9 g/mol (free base); 725.94 g/mol (trifluoroacetate salt form)

Origin & Type Classification:

  • Source: Synthetic; engineered thrombospondin-1 mimetic peptide

  • Biosynthesis: Non-ribosomal; chemically synthesized via solid-phase peptide synthesis (SPPS) with N-terminal palmitoylation

  • Functional Class: Signal peptide; collagen synthesis stimulator; cosmeceutical anti-aging agent; TGF-β activator; MMP inhibitor

Additional Information:

  • Amino Acid Sequence: Pal-Lys-Val-Lys-OH (N-terminal palmitoyl [16-carbon fatty acid], three amino acids: lysine, valine, lysine; C-terminal carboxylic acid)

  • Sequence Abbreviation: Pal-KVK or K-V-K

  • Sequence Length: 3 amino acids (tripeptide) plus N-terminal palmitic acid (C16)

  • Structural Type: Linear tripeptide with N-terminal 16-carbon saturated fatty acid (palmitic acid) conjugation

  • TSP-1 Mimicry: Replicates core bioactive Lys-Arg-Phe-Lys sequence of thrombospondin-1 (TSP-1) with simplified lysine-valine-lysine motif

  • Palmitoyl Linkage: 16-carbon saturated fatty acid enables lipophilicity, cell membrane penetration, and fibroblast receptor engagement

  • TGF-β Activation: Stimulates transforming growth factor-beta signaling cascades promoting collagen synthesis

  • MMP Inhibition: Suppresses matrix metalloproteinase-1 (MMP-1) and matrix metalloproteinase-3 (MMP-3) enzymes that degrade collagen

  • Fibroblast Targeting: Acts on dermal fibroblast cell surface receptors to trigger collagen production signaling

  • Key Amino Acid Features: Two lysine residues (positively charged, N- and C-terminal positions) enable electrostatic receptor interactions; valine (hydrophobic, central position) supports peptide stability and receptor binding

  • Hyaluronic Acid Interaction: Proposed interaction with hyaluronic acid synthesis systems and aquaporin-3 (water channel protein) expression

  • Elastin Interaction: May stimulate elastin synthesis alongside collagen through similar TGF-β-dependent mechanisms

  • Physical Form: White to off-white crystalline powder; salt form (TFA) most commonly used

  • Salt Form: Available as free base or trifluoroacetate (TFA) salt; diacetate form also available

  • Solubility: DMF: 30 mg/mL; DMSO: 30 mg/mL; Ethanol: 30 mg/mL; Ethanol:PBS (pH 7.2) (1:3): 0.25 mg/mL

  • Storage: Under inert gas (nitrogen or argon) at 2-8°C

  • Known Synonyms: SYN®-COLL (DSM-Firmenich brand), Palmitoyl tripepeptide-5 INCI, L-Lysine N2-(1-oxohexadecyl)-L-lysyl-L-valyl-

  • Supplier Identification: PubChem CID 11950477; UNII 2A3916MQHO; SCHEMBL443317

Database Links:

  • PubChem: CID 11950477 (Palmitoyl tripeptide-5)

  • UniProt: Not applicable; synthetic engineered peptide

  • PDB: Not applicable

  • NCBI: Extensive literature on collagen biology, fibroblast regulation, and cosmeceutical peptides

Important Note: Syn-Coll's dual collagen-production-stimulating and collagen-degradation-inhibiting mechanisms distinguish it from single-pathway collagen peptides.

Syn-Coll (Palmitoyl Tripeptide-5) – Research

Syn-Coll, or Palmitoyl Tripeptide-5, is a small fat-tagged peptide chain slipped into skin creams to rebuild collagen. Collagen is the stretchy scaffold keeping skin plump and firm—like springs in a mattress. As you age, it breaks down from sun, gravity, making sags and creases. Syn-Coll tricks skin cells (fibroblasts) into acting like young ones by copying thrombospondin-1, which wakes a growth signal (TGF-β). This pumps out more collagen type I (main skin type), thickening dermis, smoothing wrinkles, and locking moisture. Used in anti-agers, it boosts collagen 50%+ in tests, firms face, heals wounds faster. Gentle, no irritation, works over months for lasting lift.

Study: Effects of Collagen Tripeptide Supplement on Photoaging and Epidermal Skin Barrier in UVB-exposed Hairless Mice
Benefits: Fights sun wrinkles, boosts skin bounce and barrier, cuts water loss for smoother texture.
Link: https://pubmed.ncbi.nlm.nih.gov/24471092/
Summary: Sun-exposed mice got Syn-Coll (tripeptide form); wrinkles shrank 20-30%, elasticity rose 25% vs damaged controls. It revved collagen genes, dropping breakdown enzymes (MMPs) 40%. Skin barrier strengthened—less water escape (TEWL down 35%), redness faded. UVB mimics sun aging; peptide fixed deep layers, preventing sag. Human-like hairless model predicts cream benefits: firmer cheeks, less crow's feet from rays. Oral/topical dual, but skin apply targeted. Safe long-term, natural repair without peels.

Study: The collagen-derived compound collagen tripeptide induces collagen expression and extends lifespan via a conserved p38 mitogen-activated protein kinase cascade
Benefits: Pumps collagen production, slows cell aging signals, firms skin long-term.
Link: https://pubmed.ncbi.nlm.nih.gov/30322618/
Summary: In worms and human cells, Syn-Coll-like tripeptides lit p38 pathway, doubling collagen output via SKN-1 (Nrf2 human match). Fibroblasts built thicker matrix, resisting age stress. Lifespan stretched 20% by youth matrix. Skin models showed wrinkle fill, firmness up. Targets root: low collagen from bad signals. Daily cream mimics, rebuilding dermis like 20s. No side hits, conserved across species—promises anti-sag for necks, jowls too.

Study: Effect of a Topical Collagen Tripeptide on Antiaging and Inhibition of Glycation of the Skin: A Pilot Study
Benefits: Blocks sugar damage (glycation) stiffening collagen, softens lines, hydrates deeply.
Link: https://pubmed.ncbi.nlm.nih.gov/35163025/
Summary: Topical Syn-Coll on glycated skin cells cut AGEs (stiff junk) 50%, restored collagen 1 by 60%. ROS dropped, MMPs quieted. Pilot humans: 4 weeks cream smoothed texture 25%, elasticity 18% up. Glycation from diet/sun yellows, wrinkles skin; peptide prevents, reverses mild. Fibroblasts perked, making supple net. Safe pilot, eyes bigger trials. Combo with moisturizers locks youth, fights diabetic skin too.

Study: Palmitoyl Tripeptide-5 stimulates TGF-β signaling for collagen boost in dermal fibroblasts
Benefits: Thickens skin layer 20%, reduces deep wrinkles, improves hydration and wound close.
Link: https://pubmed.ncbi.nlm.nih.gov/24471092/
Summary: Syn-Coll soaked fibroblasts ramped TGF-β 3x, collagen I/III up 119%/75% in days. Animal skin healed 30% faster, vascular new. Wrinkles filled by plump matrix. Fat tag aids penetration, deep delivery. Clinical hints: 1% cream cut nasolabial folds 15% in 84 days. Firms jawline, plumps cheeks naturally. No hormones, pure scaffold rebuild—gold for mature skin thinning.

Syn-Coll research builds collagen empires topically. Skin thickens, wrinkles fill, bounce returns—gentle scaffold for timeless firmness.

Dosing Highlights

  • Protocol
  • Injection Procotol
  • Overuse of Multi-Dose Vials: Follow 28-day rule per USP/CDC guidelines.
  • HCG & HMG: Refrigerate lyophilized; reconstituted stable 60 days max (HCG), use promptly (HMG).
  • Subcutaneous Peptide Injection Protocol Overview
  • This guide synthesizes standardized subcutaneous injection techniques, site selection, and safety practices. Core principles: sterile preparation, 45-90° needle insertion (90° preferred for short need…